Full Text Journal Articles by
Author Andrea Behne

Advertisement

Find full text journal articles








Antithrombotic Treatment for Peripheral Arterial Occlusive Disease.

David Hardung, Andrea Behne, Mehmet Boral, Carsten Giesche, Ralf Langhoff,

<h4>Background</h4>Patients with peripheral arterial occlusive disease (PAOD) are at elevated risk for cardiovascular events and vascular events affecting the limbs. The goals of antithrombotic treatment are to keep vessels open after revascularization, to prevent cardiovascular events, and to lessen the frequency of peripheral ischemia and of amputation.<h4>Methods</h4>This review is based ... Read more >>

Dtsch Arztebl Int (Deutsches Arzteblatt international)
[2021, 118(Forthcoming):]

Cited: 0 times

View full text PDF listing >>



[Dual Pathway Inhibition in Atherosclerosis - Which Patients Benefit?]

David Hardung, Andrea Behne, Ralf Langhoff,

Dual antithrombotic therapy (DAT) with low-dose rivaroxaban in combination with acetylsalicylic acid (ASA) is available to patients with stable atherosclerotic disease as a new therapeutic option.The results of the COMPASS trial demonstrate a significant relative risk reduction of cardiovascular outcomes by 24 % with low-dose DAT in patients with stable peripheral ... Read more >>

Dtsch Med Wochenschr (Deutsche medizinische Wochenschrift (1946))
[2019, 144(20):1384-1389]

Cited: 0 times

View full text PDF listing >>



Advertisement

Promising role of drug-coated balloons in the tibial vessels?

Ralf Langhoff, Andrea Behne, Eva E Buschmann,

To judge on the role of drug-coated balloons (DCB) in below-the-knee (BTK) artery interventions, we analyzed randomized trials which compare coated to non-coated balloons and additionally a direct comparison of drug-eluting stents (DES) with DCB. As angioplasty with non-coated balloons is per guideline-recommendation still standard of care for below- the-knee ... Read more >>

J Cardiovasc Surg (Torino) (The Journal of cardiovascular surgery)
[2016, :]

Cited: 0 times

View full text PDF listing >>



Promising role of drug-coated balloons in the tibial vessels?

Ralf Langhoff, Andrea Behne, Eva Buschmann,

In order to assess the role of drug-coated balloons (DCB) in below-the-knee (BTK) artery interventions, we analyzed randomized trials which compare coated to non-coated balloons and additionally a direct comparison of drug-eluting stents (DES) with DCB. As angioplasty with non-coated balloons is per guideline-recommendation still standard of care for below-the-knee ... Read more >>

J Cardiovasc Surg (Torino) (The Journal of cardiovascular surgery)
[2016, 57(5):667-676]

Cited: 0 times

View full text PDF listing >>



Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial.

Michael Werk, Thomas Albrecht, Dirk-Roelfs Meyer, Mohammed Nabil Ahmed, Andrea Behne, Ulrich Dietz, Götz Eschenbach, Holger Hartmann, Christian Lange, Beatrix Schnorr, Heiner Stiepani, Giuseppe Biondi Zoccai, Enrique Lopez Hänninen,

<h4>Background</h4>Peripheral percutaneous transluminal angioplasty is fraught with a substantial risk of restenosis and reintervention. A drug-eluting balloon (DEB) based on a novel coating was compared with uncoated balloons in patients undergoing femoro-popliteal percutaneous transluminal angioplasty.<h4>Methods and results</h4>Patients with symptomatic femoro-popliteal atherosclerotic disease undergoing percutaneous transluminal angioplasty were randomized to paclitaxel-coated ... Read more >>

Circ Cardiovasc Interv (Circulation. Cardiovascular interventions)
[2012, 5(6):831-840]

Cited: 158 times

View full text PDF listing >>





Advertisement

Disclaimer
0.7948 s